Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 207-938-1 | CAS number: 502-44-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
e-Caprolactone was not irritating to the skin of rabbits, but was found to be an eye irritant and should be classified as such under CLP.
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 16th to 19th September 1991
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Proprietary study conducted according to guidelines and GLP.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 404 (Acute Dermal Irritation / Corrosion)
- GLP compliance:
- yes (incl. QA statement)
- Species:
- rabbit
- Strain:
- New Zealand White
- Details on test animals or test system and environmental conditions:
- Three SPF-derived male New Zealand White rabbits (2.5-3.0kg) were obtained from Harlan Olac and acclimatised for 11 days. The rabbits were individually housed in stainless steel wire cages; sawdust, woodchip, or any other extraneous material that may cause skin irritation were excluded. The rabbits received 80g standard laboratory diet per day, and they had free access to the food and water. The animal room was maintained at a temperature of 19-20oC, relative humditiy 55-72%, artificial light from 7am till 7pm, radio-sound from 7am till 7pm, and approximately 16 air changes per hour.
- Type of coverage:
- occlusive
- Preparation of test site:
- shaved
- Vehicle:
- unchanged (no vehicle)
- Controls:
- no
- Amount / concentration applied:
- 0.5g of test material 2x3cm area of skin.
- Duration of treatment / exposure:
- The patches were secured in place for 4 hours.
- Observation period:
- Observations were made at 30-60 minutes, and 24, 48 and 72 hours after substance removal.
- Number of animals:
- Three male rabbits.
- Details on study design:
- Areas on the backs of 3 rabbits were shaved (2x3cm). 0.5g e-Caprolactone was applied directly to the shaved skin, and held in place by occlusive Blenderm tape and standard adhesive tape. Elizabethan collars were fitted to the rabbits to prevent them disturbing the treatment area. The substance was left in place for 4 hours. Following this the collars and tape were removed, and the skin wiped to remove any remaining residue. Observations were made at 30 minutes, and 24, 48 and 72 hours after substance removal.
Treatment sites were scored based on erythema and eschar formation, and oedema formation (according to the scoring system in OECD 404). - Irritation parameter:
- erythema score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 4
- Reversibility:
- other: not applicable
- Remarks on result:
- other: No effects noted
- Irritation parameter:
- edema score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 4
- Reversibility:
- other: not applicable
- Remarks on result:
- other: No effects noted
- Irritant / corrosive response data:
- No erythma or oedema was observed in the three rabbits after 4 hours skin exposure to e-Caprolactone.
- Other effects:
- No other effects reported.
- Interpretation of results:
- GHS criteria not met
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- The application of e-Caprolactone caused no irritation to the shaven intact skin of 3 rabbits, therefore the substance was classified as non-irritant according to EEC labelling regulations.
- Executive summary:
The primary irritation of e-Caprolactone to rabbit skin was investigated. 0.5 g e-Caprolactone was applied directly to an area of shaved skin on the backs of the rabbits (2x3cm), and held in place for 4 hours using occlusive tape. After removal of the tape the skin was wiped to remove any remaining residue, and observations were made at 0.5, 24, 48 and 72 hours after removal. No erythema or oedema was observed in the rabbits at any time point. Classification as a skin irritant is not required on the basis of this study.
Reference
No erythma or oedema was observed in the three rabbits after 4 hours skin exposure to e-Caprolactone, at any time point post-substance removal.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 4th November to 2nd December 1991
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Proprietary study conducted according to guidelines and GLP
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 405 (Acute Eye Irritation / Corrosion)
- GLP compliance:
- yes (incl. QA statement)
- Species:
- rabbit
- Strain:
- New Zealand White
- Details on test animals or tissues and environmental conditions:
- SPF-derived male New Zealad White rabbits (one animal weighed 1.8-2.2kg, three weighed 2.5-3.0kg), obtained from Harlan Olac. Animals underwent an 11 day acclimatisation period. Rabbits were housed individually in stainless steel wire cages without sawdust or woodchips (i.e. no extraneous material that might produce eye irritation). They received 80g food per day (standard laboratory diet), with free access to the food and water. Temperature of the animal room was maintained at 19-22oC, relative humidity 52-72%, artificial light from 7am till 7pm, radio-sound from 7am till 7pm, and approximately 16 air changes per hour.
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent no treatment
- Amount / concentration applied:
- 0.1ml e-Caprolactone applied to conjunctival sac.
- Duration of treatment / exposure:
- Substance was applied to conjunctival sac, and eyelid held closed for approximately 1 second.
- Observation period (in vivo):
- Observations were made at 1, 24, 48, 72 hours and 7 days after treatment.
- Number of animals or in vitro replicates:
- Initially 4 animals were used, one of these animals was injured and euthanased 1 hour post-treatment. A replacement rabbit was obtained from the supplier.
- Details on study design:
- Four rabbits were used. 0.1ml test substance was dropped into the conjuctival sac of the left eye. Eye reactions were scored at 1, 24, 48, 72 hours and 7 days after treatment. The scoring system used was that according to Draize (1944), and the results were interpreted according to the Commission Directive 91/325/EEC. The right eye remained untreated to serve as a control.
- Irritation parameter:
- cornea opacity score
- Remarks:
- opacity
- Basis:
- mean
- Time point:
- 24/48/72 h
- Score:
- 1.78
- Max. score:
- 4
- Reversibility:
- fully reversible within: 7 days
- Irritation parameter:
- iris score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Score:
- 0.89
- Max. score:
- 2
- Reversibility:
- fully reversible within: 7 days
- Irritation parameter:
- conjunctivae score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Score:
- 1.44
- Max. score:
- 3
- Reversibility:
- fully reversible within: 7 days
- Irritation parameter:
- chemosis score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Score:
- 0.89
- Max. score:
- 4
- Reversibility:
- fully reversible within: 7 days
- Irritant / corrosive response data:
- At 1 hour very slight opacity, iritis, redness and very slight chemosis were observed in three rabbits, and slight iritis, redness and chemosis was observed in the fourth. Severe discharge was observed in animal's 1-3 and moderate discharge in animal 4. The following observations are limited to 3 animals: at 24 hours slight opacity and iritis were observed, slight to moderate redness was observed. Very slight to sight chemosis was observed. At 48 hours opacity was very slight to slight. Redness was slight to moderate. Chemosis was very slight. At 72 hours very slight to slight opacity and slight iritis were observed. Slight to moderate redness were observed. All symptoms had disappeared by day 7.
- Other effects:
- No additional effects.
- Interpretation of results:
- Category 2 (irritating to eyes) based on GHS criteria
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- According to labelling regulations e-Caprolactone is classified as irritating to the eye.
- Executive summary:
The primary irritation of e-Caprolactone to the eye of male rabbits was determined in this guideline study. 0.1ml substance was introduced to the conjunctival sac of the left eye of three rabbits (the right eye remained untreated to serve as a control). The eyes of the rabbits were examined and the ocular reactions graded at intervals up to and including 7 days after treatment. Various signs of irritation were observed (corneal opacity, iris lesion, conjunctival erythema, chemosis and discharge), lthough all symptoms were reversible by Day 7. The substance requires classification as an eye irritant according to Regulation (EC) No 1272/2008 (CLP) and according to Directive 67/548/EEC. It is classified as an eye irritant and assigned the symbol Xi and the risk-phrase R36 "Irritating to eyes". It is an eye irritant category 2 and is assigned the pictogram GHS07 with the signal word "warning" and the hazard statement H319 "causes serious eye irritation".
Reference
Scores for ocular effects
Observation |
1h |
24h |
48h |
72h |
Mean (24-72h) |
7d |
|
Cornea |
Opacity |
1,1,0 |
2,2,2 |
2,2,1 |
2,2,1 |
1.78 |
0,0,0 |
Iris |
Lesion |
1,1,1 |
1,1,1 |
1,1,1 |
1,1,0 |
0.89 |
0,0,0 |
Conjunctivae |
Erythema |
1,1,1 |
2,2,1 |
1,2,1 |
1,2,1 |
1.44 |
0,0,0 |
Chemosis |
1,1,2 |
2,1,1 |
1,1,1 |
0,1,0 |
0.89 |
0,0,0 |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Additional information
Skin irritation
The primary irritation of e-Caprolactone to rabbit skin was investigated in a GLP study according to OECD method 404 (Janssen, 1991). 0.5 g e-Caprolactone was applied directly to an area of shaved skin on the backs of the rabbits (2x3cm), and held in place for 4 hours using occlusive tape. After removal of the tape the skin was wiped to remove any remaining residue, and observations were made at 0.5, 24, 48 and 72 hours after removal. No erythema or oedema was observed in the rabbits at any time point. Classification as a skin irritant is not required on the basis of this study.
Eye irritation
The primary irritation of e-Caprolactone to the eye of male rabbits was determined in a GLP study according to OECD method 405 (Janssen, 1991). 0.1ml substance was introduced to the conjunctival sac of the left eye of three rabbits (the right eye remained untreated to serve as a control). The eyes of the rabbits were examined and the ocular reactions graded at intervals up to and including 7 days after treatment. Various signs of irritation were observed (corneal opacity, iris lesion, conjunctival erythema, chemosis and discharge), although all symptoms were reversible by Day 7. The substance requires classification as an eye irritant according to CLP.
Effects on eye irritation: irritating
Justification for classification or non-classification
No evidence of skin irritation was seen in a guideline study in the rabbit. Evidence of eye irritation sufficient to trigger classification was seen in a guideline study in the rabbit.
The available data indicate that the substance requires classification as an eye irritant according to Regulation (EC) No 1272/2008 (the CLP Regulation). It is an eye irritant category 2 and is assigned the pictogram GHS07 with the signal word "warning" and the hazard statement H319 "causes serious eye irritation".
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.